13D Filing: Osmium Partners and Intersections Inc (INTX)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549

SCHEDULE 13D

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

RULE 13d-2(a)

(Amendment No. 2)*

INTERSECTIONS INC.
(Name
of Issuer)

Common Stock, par value $0.01
(Title of Class
of Securities)

460981301
(CUSIP Number)

Osmium Partners, LLC
300 Drakes Landing Road,
Suite 172
Greenbrae, CA 94904
Attention: John H. Lewis

Telephone: (415) 785-4044
(Name, Address and Telephone
Number of Person Authorized to Receive Notices and Communications)

August 8, 2017
(Date of Event Which Requires
Filing of this Statement)

If the filing person has previously filed a statement on
Schedule 13G to report the acquisition that is the subject of this Schedule 13D,
and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g),
check the following box [   ].

Note. Schedules filed in paper format shall include a
signed original and five copies of the schedule, including all exhibits.
See Rule 13d-7(b) for other parties to whom copies are to be sent.

     The information required on the
remainder of this cover page shall not be deemed to be filed for the purpose
of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the
liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes.)

CUSIP No. 460981301

CUSIP No. 460981301

CUSIP No. 460981301

CUSIP No. 460981301

CUSIP No. 460981301

CUSIP No. 460981301

EXPLANATORY NOTE

This Amendment No. 2 to Schedule 13D (Amendment No. 2) is
being filed with respect to the beneficial ownership of the Reporting Persons in
Intersections Inc. (Intersections or the Issuer). This Amendment No. 2
supplements the Schedule 13D as previously filed on February 15, 2015 (as
amended, the Schedule 13D). Each Item below amends and supplements the
information disclosed under the corresponding Item of Schedule 13D. Unless
otherwise indicated herein, capitalized terms used but not defined in this
Amendment No. 2 shall have the same meaning herein as are ascribed to such terms
in Schedule 13D. Except as set forth herein, this Amendment No. 2 does not
modify any of the information previously reported by the Reporting Persons in
the Schedule 13D.

This Amendment No. 2 is being filed to report the resignation
of Mr. Lewis from the board of directors of the Issuer effective on August 8,
2017.

ITEM 5. Interest in Securities of the Issuer

(a) The Reporting Persons beneficially own:

Each Reporting Person disclaims beneficial ownership with
respect to any shares of Common Stock other than the shares owned directly and
of record by such Reporting Person.

The percentages set forth in this response are based on the
23,873,853 shares of Common Stock outstanding as of May 5, 2017, as reported by
the Issuer to Osmium Partners.

(b) Osmium Partners and Mr. Lewis may be deemed to share with
Fund I, Fund II, Fund III and Fund IV (and not with any third party) the power
to vote or direct the vote of and to dispose or direct the disposition of the
1,629,701 shares of Common Stock, 826,792 shares of Common Stock, 460,812 shares
of Common Stock and 530,810 shares of Common Stock reported herein,
respectively. Mr. Lewis, individually, has the power to vote or direct the vote
of and to dispose or direct the disposition of the 31,165 shares of Common Stock
reported herein as individually owned by him.

(c) The following Reporting Persons engaged in the following
transactions with respect to the Issuers Common Stock during the 60 days
preceding August 8, 2017 and the 60 days preceding the date of this filing:

John H. Lewis

Other than the foregoing, no transactions in the Common Stock
have been effected by the Reporting Persons in the 60 days preceding August 8,
2017 and the 60 days preceding the date of this filing.

(d) Not applicable.

(e) Not applicable.

ITEM 7. Material to be Filed as Exhibits.

Exhibit
1             Joint
Filing Agreement *

*Previously Filed

SIGNATURE

   After reasonable inquiry and to the best of my knowledge and
belief, the undersigned certify that the information set forth in this statement
is true, complete and correct.

Dated: August 10, 2017